Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04551469 · ClinicalTrials.gov registry record · NA

A Randomized Clinical Trial to Measure Efficacy of Music on Cardiac Surgery Patients

A NA study of Cardiac Surgery, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT04551469: Active NA study of Cardiac Surgery, sponsored by Massachusetts General Hospital.

NCT04551469 is a NA study of Cardiac Surgery that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 120 participants, below the 739-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04551469, a NA study of Cardiac Surgery, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Cardiac surgery involves both physical and psychological stress for patients from time of decision to the recovery period. The physical aspects and the impact on the psychological experience makes the post-operative period a difficult time for patients. Patients often experience emotional distress, uncertainty, and fear. A non-pharmacological intervention of music may affect the patient's perception of early recovery with little to no side effects. Current research has demonstrated efficacy in psychological and physical responses. there is limited data on the endocrinologic (cortisol) and immunologic biomarkers Immunoglobulin A to a music intervention. Therefore, the purpose of this study is to measure both psychological/physical response and biomarkers pre and post a 30-minute music intervention compared to standard of care experience A randomized, placebo-controlled, pre-post clinical trial will be initiated to demonstrate the effect that music has on the primary outcome of serum cortisol and secondary outcomes of anxiety, pain, blood pressure, heart rate, respirations, and Immunoglobulin A in adult patients after cardiac surgery.

Primary Outcome

micrograms per deciliter

Conditions Studied

Interventions

  • BEHAVIORAL music

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-07-01
Est. Completion 2025-12-30
Phase NA
Massachusetts General Hospital

2,032 total trials

What the registry record for NCT04551469 still lists

NCT04551469 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 739-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Cardiac Surgery appearing as the primary indexed condition, and to 1 intervention - of which music is the first listed.

NCT04551469 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04551469 about?

NCT04551469 is a clinical study titled "A Randomized Clinical Trial to Measure Efficacy of Music on Cardiac Surgery Patients". Cardiac surgery involves both physical and psychological stress for patients from time of decision to the recovery period. The physical aspects and the impact on the psychological experience makes the post-operative period a difficult time for patients. Patients often experience emotional distress, ...

What is the current status of trial NCT04551469?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2021-07-01. Estimated completion is 2025-12-30.

What conditions does trial NCT04551469 study?

This clinical trial studies the following conditions: Cardiac Surgery.

What interventions are being tested in trial NCT04551469?

The interventions under investigation include: music (BEHAVIORAL).

Who is sponsoring clinical trial NCT04551469?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04551469 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04551469's enrollment target sits among peer trials

120 12th of 19 higher than 8 of 19 other Cardiac Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiac Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04551469, the US trial registry maintained by the National Library of Medicine. NCT04551469 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.